Literature DB >> 16972817

The MMPI-2 Restructured Clinical Scales: a paradigmatic shift in scale development.

Richard Rogers1, Kenneth W Sewell, Kimberly S Harrison, Mandy J Jordan.   

Abstract

Tellegen et al. (2003) proposed fundamental changes in MMPI-2 (Butcher, Dahlstrom, Graham, Tellegen, & Kaemmer, 1989) scale development by discarding empirical scale development in favor of construct validation via Jackson's (1970) sequential system of scale development. As a result of their efforts, a general distress factor (Demoralization) was identified and 8 Restructured Clinical (RC) Scales were developed. Using 7,330 clinical cases from Caldwell's (1997) data set, in this study, we sought to cross-validate the MMPI-2 RC Scales. Scale homogeneity was confirmed with high alpha coefficients and interitem correlations in the expected range. We also achieved a major objective of reducing interscale correlations. In replicating Tellegen et al.'s principal components analysis, we achieved a high concordance for 6 of the 8 RC Scales. We critically examine these results in light of Jackson's construct validation. We discuss the clinical usefulness of the MMPI-2 RC Scales within the context of current and future research.

Mesh:

Year:  2006        PMID: 16972817     DOI: 10.1207/s15327752jpa8702_03

Source DB:  PubMed          Journal:  J Pers Assess        ISSN: 0022-3891


  2 in total

1.  The MMPI-2 restructured clinical scales in the assessment of posttraumatic stress disorder and comorbid disorders.

Authors:  Erika J Wolf; Mark W Miller; Robert J Orazem; Mariann R Weierich; Diane T Castillo; Jaime Milford; Danny G Kaloupek; Terence M Keane
Journal:  Psychol Assess       Date:  2008-12

2.  MMPI-2 Profile of French Transsexuals: The Role of Sociodemographic and Clinical Factors. A cross-sectional design.

Authors:  Mireille Bonierbale; Karine Baumstarck; Aurélie Maquigneau; Audrey Gorin-Lazard; Laurent Boyer; Anderson Loundou; Pascal Auquier; Christophe Lançon
Journal:  Sci Rep       Date:  2016-04-12       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.